8/2/26
SHANGHAI CARTHANE CO.,LTD. (603037.SS) Thesis: Recent declines in net income and rising raw material costs have raised concerns about profitability, overshadowing potential growth from new partnerships.
★ Analysts see FY2027 revenue reaching $492M — -10.4% growth in a single year.
What Could Go Wrong 1 A significant increase in raw material costs has led to a 15% decline in gross margins, pressuring profitability in the near term. 2 Declining consumer sentiment in China could lead to reduced automotive sales, negatively impacting demand for parts. 3 Technological disruption from alternative materials in automotive manufacturing 4 Regulatory changes that may impose stricter environmental standards 5 Increased competition from domestic and international automotive parts manufacturers 6 Potential for price wars in the polyurethane segment 7 Moderate financial risk due to reliance on operational cash flow for capital expenditures 8 Potential liquidity risk if cash flow does not improve amid declining net income 8.0 11.2 14.4 17.5 20.7 9.86 603037.SS Daily 9.86 Mar '26 Apr '26 Jun '26 Jul '26
My Notes "Management noted, 'While we are optimistic about our new ventures, current market conditions are challenging our margins.'" Moat: The company's proprietary formulations and established relationships with major automakers provide a moderate level of competitive… Watch: The rise of alternative materials and technologies in automotive manufacturing poses a significant long-term threat. value - Investors may be drawn to the company's low debt levels and potential for recovery as automotive demand stabilizes. Moderate sensitivity as higher interest rates could impact consumer financing for vehicle purchases… Watch on earnings: Polyurethane raw material prices, Automotive production statistics in China, Gross margin trends. One Sentence Summary: The bear case: a significant increase in raw material costs has led to a 15% decline in gross margins, pressuring profitability in the near term.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.